Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 226 AL 240

Amyloid-beta immunotherapy for Alzheimer's disease

Fu HJ, Liu B, Frost JL, Lemere CA.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):197-206. doi: 10.2174/187152710791012017.

Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer's disease-view from the bedside

Fiala M.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):192-6. doi: 10.2174/187152710791012044.

Assessing activation states in microglia

Colton C, Wilcock DM.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):174-91. doi: 10.2174/187152710791012053.

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

Hickman SE, El Khoury J.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):168-73. doi: 10.2174/187152710791011982.

Microglia and inflammation in Alzheimer's disease

Mandrekar-Colucci S, Landreth GE.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):156-67. doi: 10.2174/187152710791012071.

Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease

Cole GM, Frautschy SA.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):140-8. doi: 10.2174/187152710791011991.

Inflammation, immunity, and Alzheimer's disease

Town T.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):129-31. doi: 10.2174/187152710791012008.

Nicotinic acetylcholine receptor interaction with beta-amyloid: molecular, cellular, and physiological consequences

Parri RH, Dineley TK.

Curr Alzheimer Res. 2010 Feb;7(1):27-39. doi: 10.2174/156720510790274464.

The pulse of drug development for Alzheimer's disease

Rafii MS.

Rev Recent Clin Trials. 2010 Jan;5(1):57-62. doi: 10.2174/157488710790820490.

Exploring new indications for statins beyond atherosclerosis: Successes and setbacks

Waters DD.

J Cardiol. 2010 Mar;55(2):155-62. doi: 10.1016/j.jjcc.2009.12.003. Epub 2010 Jan 7.

Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies

Bonda DJ, Wang X, Perry G, Smith MA, Zhu X.

Drugs Aging. 2010 Mar 1;27(3):181-92. doi: 10.2165/11532140-000000000-00000.

Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice

Oster T, Pillot T.

Biochim Biophys Acta. 2010 Aug;1801(8):791-8. doi: 10.1016/j.bbalip.2010.02.011. Epub 2010 Mar 6.

Calcium signaling and amyloid toxicity in Alzheimer disease

Demuro A, Parker I, Stutzmann GE.

J Biol Chem. 2010 Apr 23;285(17):12463-8. doi: 10.1074/jbc.R109.080895. Epub 2010 Mar 8.

Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease

Domek-Łopacińska KU, Strosznajder JB.

Mol Neurobiol. 2010 Jun;41(2-3):129-37. doi: 10.1007/s12035-010-8104-x. Epub 2010 Mar 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias